Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 5/31/2025Recent Official and Executive Moves
  • 5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine
  • 5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...
  • 5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
  • 5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies
  • 5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...
  • 5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...
  • 5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...
  • 5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...
  • 5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies
  • 5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...
  • 5/31/2025Ivonescimab Hits Key Milestone in Phase III HARMONi Trial for EGFR-Mut...
  • 5/31/2025Former CFDA Commissioner Bi Jingquan Under Investigation for Serious ...
  • 5/29/2025First Patient Dosed in YK012 Trial -The World's First TCE Therapy for ...
  • 5/29/2025CDE Solicits Comments on Draft Technical Considerations for NMR Studi...
  • 5/29/2025CDE Issues Guideline on Production Site Change Research for Licensed B...
  • 5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
  • 5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
  • 5/29/2025AusperBio Secures $50M in Series B+ Financing
  • 5/29/2025Rona Unveils Promising Preclinical Data for Annual RNAi Therapy
  • 5/29/2025Livzon Acquires Majority Stake in Vietnam's Imexpharm for $221 Million
  • 5/29/2025China Grants Conditional Approval to Hengrui's Famitinib
  • 5/29/2025China Approves Zelgen's Gecacitinib
  • 5/29/2025China Grants Conditional Approval to Two HER2-Targeted Therapies for A...
  • 5/29/2025Kanion's Generic Sumatriptan/Naproxen Gains Approval in China
  • 5/29/2025China Approves Two New CDK4/6 Inhibitors for Advanced Breast Cancer
  • 5/29/2025Merck Pursues Global Approvals for Pimicotinib Following Positive Phas...
  • 5/29/2025Kelun-Biotech Initiates Phase 1 Trial for SKB571, a Bispecific ADC Tar...
  • 5/29/2025Novartis Secures NMPA Approval for Beovu for DME in China
  • 5/29/2025Minghui Advances IGF-1R Antibody MHB018A to Phase 3 for TED
  • Page:1/50 Total number of articles:1490: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group